Trial intelligence / Profile preview

TIVA vs Inhalation Anesthesia in Breast Cancer Surgery

NCT02089178Terminated

Sponsor
Yonsei University
Start
Feb 2014
Primary completion
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of propofol in breast cancer, sponsored by Yonsei University. Primary endpoint: Number of Natural Killer cells at 24 hours. Started Feb 2014; status: terminated.

02

Drugs

propofol
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT02089178.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02089178.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call